He Kun, Wu Dong
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Clinical Epidemiology Unit, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Beijing 100730, China.
Therap Adv Gastroenterol. 2023 Apr 17;16:17562848231167283. doi: 10.1177/17562848231167283. eCollection 2023.
Behcet's disease (BD) is a chronic and recurrent systemic vasculitis involving large, medium and small blood vessels as well as arteries and veins. BD with predominant gastrointestinal manifestations is diagnosed as intestinal BD, which is associated with severe complications such as massive gastrointestinal hemorrhage, perforation, and obstruction. Recently, treat-to-target (T2T) strategies have been successfully used in many chronic diseases and been suggested in the management of BD, while there are no related reviews about the global treatment strategy including treatment principles and targets for intestinal BD in detail. Herein, we review the treatment principles from the aspects of departments of Rheumatology and Gastroenterology. In addition, treatment targets of intestinal BD are reviewed from three aspects such as evaluable markers, effective markers and potency-ratio markers. Some definitions and conceptions from inflammatory bowel disease (IBD) bring us reference and enlightenments.
白塞病(BD)是一种慢性复发性全身性血管炎,累及大、中、小血管以及动脉和静脉。以胃肠道表现为主的BD被诊断为肠道白塞病,其与严重并发症相关,如大量胃肠道出血、穿孔和梗阻。最近,达标治疗(T2T)策略已成功应用于许多慢性疾病,并被建议用于BD的管理,然而,目前尚无关于包括肠道白塞病治疗原则和目标在内的全球治疗策略的详细相关综述。在此,我们从风湿病学和胃肠病学部门的角度回顾治疗原则。此外,从可评估标志物、有效标志物和效价比标志物三个方面对白塞病的治疗靶点进行了综述。炎症性肠病(IBD)的一些定义和概念给我们带来了参考和启示。